21 Trademark Results found for "*PDI"

Also try searching for:

PDI*

Details	Status	Class/Description
TRINITYRAIL PDI Trinity Industries, Inc. 2095568 29 Mar 2021	REGISTERED on 1 Nov 2024	Railcar inspection services, namely providing inspection services and ... Class 042 Class 042 Computer & Software Services & Scientific Services Railcar inspection services, namely providing inspection services and the results of the inspection services to customers using a web-based platform; Railcar inspection services
PDI Robert Ng 2070495 11 Dec 2020	FORMALIZED on 3 Dec 2024	Drive-line components designed and manufactured for Automobiles, Light... Class 012 Class 012 Vehicles and Products for locomotion by land, air or water Drive-line components designed and manufactured for Automobiles, Light Trucks, All-Terrain Vehicles (ATVs), Utility Terrain Vehicles (UTVs) such as Axles, Drive Shaft, Brake Pad, In Board Joint, Out Board Joint, Universal Joint, Wheel Spacer, Windshield and Electric Power Steering Unit, Ball Joint, Propeller Shaft, Bracket Lift Kit, A-Arm, CV Joint, Transmission Propeller Shaft, CV Boot Kit, Heim Joint, Tie Rod, Power Steering Components and Differential Component.
LAGOPDI BRISTOL-MYERS SQUIBB COMPANY 2054828 30 Sept 2020	REGISTERED on 19 Feb 2024	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as antiinfectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.
YEVUPDI BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION) 1824929 28 Feb 2017	REGISTERED on 16 Jan 2020	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents
YEOPDI BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION) 1798073 30 Aug 2016	REGISTERED on 27 Aug 2019	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents
COMCAPDI BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION) 1797944 29 Aug 2016	REGISTERED on 27 Aug 2019	Pharmaceutical preparations for human use for the treatment and preven... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection, hepatitis; pharmaceutical preparations for human use relating to metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents
LERVIPDI BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION) 1797943 29 Aug 2016	ABANDONED SECTION 36 on 27 Feb 2018	Pharmaceutical preparations for human use Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use
DUAPDI BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION) 1794157 3 Aug 2016	ABANDONED SECTION 36 on 5 Dec 2017	Pharmaceutical preparations for human use Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use
PDI ROBERT NG 1683554 2 Jul 2014	ABANDONED SECTION 36 on 22 Mar 2017	Driveline parts for automobiles, light trucks, all-terrain vehicles (A... Class 012 Class 012 Vehicles and Products for locomotion by land, air or water Driveline parts for automobiles, light trucks, all-terrain vehicles (ATVs) and utility vehicles (UTVs), namely, axles, drive shafts, cv joints and u-joints.
TAZAPDI MERCK SHARP & DOHME CORP. 1631305 14 Jun 2013	ABANDONED SECTION 40(3) on 5 Jul 2016	Pharmaceutical preparations for use in oncology Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in oncology

REGISTERED

on 1 Nov 2024

TRINITYRAIL PDI

Trinity Industries, Inc.

2095568 · 29 Mar 2021

042

Railcar inspection services, namely providing inspection services and ...

FORMALIZED

on 3 Dec 2024

PDI

Robert Ng

2070495 · 11 Dec 2020

012

Drive-line components designed and manufactured for Automobiles, Light...

REGISTERED

on 19 Feb 2024

LAGOPDI

BRISTOL-MYERS SQUIBB COMPANY

2054828 · 30 Sept 2020

005

Class 005

Pharmaceutical Products

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, heart failure, thrombosis, stroke, cancer, respiratory diseases, auto-immune diseases, rheumatoid arthritis, lupus, inflammatory bowel disease, solid organ transplant rejection, hepatitis, fibrosis, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, central nervous system depressants, central nervous system stimulants, anti-psychotics, cytokine inhibitory drugs; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as antiinfectives, and for use as anti-inflammatories; diagnostic pharmaceutical preparations for human use for increasing the heart rate and for use as medical imaging contrast agents; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of cancer; pharmaceutical preparations for use in immunotherapies; pharmaceutical preparations for use in T-cell immunotherapy; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for human use namely T-cells for medical purposes; pharmaceutical preparations for human use namely diagnostic kits consisting primarily of cells for medical laboratory use; Pharmaceutical preparations for human use for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use namely antivirals for treatment and prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; pharmaceutical preparations for human use namely monoclonal antibodies.

Pharmaceutical preparations for human use for the treatment and preven...

REGISTERED

on 16 Jan 2020

YEVUPDI

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

1824929 · 28 Feb 2017

005

Pharmaceutical preparations for human use for the treatment and preven...

REGISTERED

on 27 Aug 2019

YEOPDI

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

1798073 · 30 Aug 2016

005

Pharmaceutical preparations for human use for the treatment and preven...

REGISTERED

on 27 Aug 2019

COMCAPDI

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

1797944 · 29 Aug 2016

005

Pharmaceutical preparations for human use for the treatment and preven...

ABANDONED SECTION 36

on 27 Feb 2018

LERVIPDI

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

1797943 · 29 Aug 2016

005

Pharmaceutical preparations for human use

ABANDONED SECTION 36

on 5 Dec 2017

DUAPDI

BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)

1794157 · 3 Aug 2016

005

Pharmaceutical preparations for human use

ABANDONED SECTION 36

on 22 Mar 2017

PDI

ROBERT NG

1683554 · 2 Jul 2014

012

Driveline parts for automobiles, light trucks, all-terrain vehicles (A...

ABANDONED SECTION 40(3)

on 5 Jul 2016

TAZAPDI

MERCK SHARP & DOHME CORP.

1631305 · 14 Jun 2013

005

Pharmaceutical preparations for use in oncology

Owners

Bristol-myers squibb company (a delaware corporation) (5)

Professional disposables international inc. (a delaware corporation) (2)

Acl canada inc. (1)

Bristol-myers squibb company (1)

Evonik degussa gmbh (1)

H-investment corporation (1)

Korn ferry leadership consulting corporation (1)

Merck sharp & dohme corp. (1)

Pdi photo distributors international limited (1)

Power dynamics inc. (new jersey corporation) (1)

Categories

Class 5 (9)

Class 35 (5)

Class 1 (3)

Class 9 (3)

Class 12 (3)

Class 42 (3)

Class 3 (2)

Class 4 (2)

Class 7 (2)

Class 21 (2)

Class 41 (2)

Class 6 (1)

Class 14 (1)

Class 16 (1)

Class 17 (1)

Class 20 (1)

Class 37 (1)

Class 39 (1)

Class 44 (1)

Correspondents

Gowling wlg (canada) llp (8)

Smart & biggar lp (3)

Moffat & co. (2)

Keyser mason ball, llp (1)

Marks & clerk (1)

Vantek intellectual property llp (aka d/b/a vantek ip llp) (1)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo trademark

Trademark Name

Country Selected

Canada

$599 / 1 class + gov fee

United States

$99 / 1 class + gov fee

Canada

$599 / 1 class + gov fee

Mexico

$499 / 1 class + gov fee

European Union

$700 / 1 class + gov fee

China

$499 / 1 class + gov fee

South Korea

$699 / 1 class + gov fee

Japan

$799 / 1 class + gov fee

India

$99 / 1 class + gov fee

United Kingdom

$499 / 1 class + gov fee

Australia

$299 / 1 class + gov fee

Israel

$699 / 1 class + gov fee

United Arab Emirates

$699 / 1 class + gov fee

New Zealand

$699 / 1 class + gov fee

Brazil

$499 / 1 class + gov fee

Taiwan

$799 / 1 class + gov fee

Ukraine

$799 / 1 class + gov fee

Indonesia

$699 / 1 class + gov fee

South Africa

$499 / 1 class + gov fee

Singapore

$799 / 1 class + gov fee

Saudi Arabia

$799 / 1 class + gov fee

Afghanistan

$799 / 1 class + gov fee

Algeria

$799 / 1 class + gov fee

Argentina

$399 / 1 class + gov fee

Austria

$899 / 1 class + gov fee

Bahrain

$699 / 1 class + gov fee

Bangladesh

$599 / 1 class + gov fee

Benelux

$999 / 1 class + gov fee

Bhutan

$899 / 1 class + gov fee

Bolivia

$799 / 1 class + gov fee

Botswana

$1299 / 1 class + gov fee

British Virgin Islands

$1199 / 1 class + gov fee

Bulgaria

$799 / 1 class + gov fee

Cambodia

$799 / 1 class + gov fee

Chile

$499 / 1 class + gov fee

Colombia

$699 / 1 class + gov fee

Congo

$1199 / 1 class + gov fee

Costa Rica

$899 / 1 class + gov fee

Croatia

$899 / 1 class + gov fee

Cyprus

$999 / 1 class + gov fee

Czech Republic

$899 / 1 class + gov fee

Denmark

$799 / 1 class + gov fee

Dominican Republic

$899 / 1 class + gov fee

Ecuador

$799 / 1 class + gov fee

Egypt

$699 / 1 class + gov fee

El Salvador

$799 / 1 class + gov fee

Ethiopia

$1099 / 1 class + gov fee

France

$899 / 1 class + gov fee

Gaza

$799 / 1 class + gov fee

Germany

$899 / 1 class + gov fee

Greece

$799 / 1 class + gov fee

Guatemala

$899 / 1 class + gov fee

Haiti

$899 / 1 class + gov fee

Honduras

$899 / 1 class + gov fee

Hong Kong (SAR)

$899 / 1 class + gov fee

Hungary

$1099 / 1 class + gov fee

Iraq

$1499 / 1 class + gov fee

Italy

$899 / 1 class + gov fee

Jordan

$799 / 1 class + gov fee

Kazakhstan

$799 / 1 class + gov fee

Kenya

$899 / 1 class + gov fee

Kuwait

$799 / 1 class + gov fee

Laos

$699 / 1 class + gov fee

Lebanon

$999 / 1 class + gov fee

Lesotho

$1199 / 1 class + gov fee

Libya

$899 / 1 class + gov fee

Madrid Protocol (WIPO)

$1999 / 1 class + gov fee

Malawi

$1099 / 1 class + gov fee

Malaysia

$699 / 1 class + gov fee

Maldives

$999 / 1 class + gov fee

Morocco

$999 / 1 class + gov fee

Mozambique

$899 / 1 class + gov fee

Myanmar

$799 / 1 class + gov fee

Namibia

$799 / 1 class + gov fee

Nepal

$699 / 1 class + gov fee

Nicaragua

$899 / 1 class + gov fee

Norway

$899 / 1 class + gov fee

Oman

$1099 / 1 class + gov fee

Pakistan

$799 / 1 class + gov fee

Panama

$899 / 1 class + gov fee

Paraguay

$899 / 1 class + gov fee

Peru

$799 / 1 class + gov fee

Philippines

$899 / 1 class + gov fee

Poland

$499 / 1 class + gov fee

Portugal

$899 / 1 class + gov fee

Puerto Rico

$899 / 1 class + gov fee

Qatar

$799 / 1 class + gov fee

Romania

$899 / 1 class + gov fee

Serbia

$899 / 1 class + gov fee

Slovakia

$899 / 1 class + gov fee

Spain

$899 / 1 class + gov fee

Sri Lanka

$699 / 1 class + gov fee

Swaziland

$1299 / 1 class + gov fee

Sweden

$799 / 1 class + gov fee

Switzerland

$899 / 1 class + gov fee

Thailand

$799 / 1 class + gov fee

Tunisia

$899 / 1 class + gov fee

Turkey

$799 / 1 class + gov fee

Uganda

$699 / 1 class + gov fee

United Republic of Tanzania

$699 / 1 class + gov fee

Uruguay

$799 / 1 class + gov fee

Venezuela

$899 / 1 class + gov fee

Vietnam

$799 / 1 class + gov fee

West Bank, Palestine

$799 / 1 class + gov fee

Yemen

$1699 / 1 class + gov fee

Albania

$899 / 1 class + gov fee

Andorra

$899 / 1 class + gov fee

Angola

$1299 / 1 class + gov fee

Antigua and Barbuda

$1299 / 1 class + gov fee

Armenia

$799 / 1 class + gov fee

Azerbaijan

$799 / 1 class + gov fee

Bahamas

$1399 / 1 class + gov fee

Barbados

$1299 / 1 class + gov fee

Belgium

$999 / 1 class + gov fee

Belize

$1299 / 1 class + gov fee

Benin

$799 / 1 class + gov fee

Bosnia and Herzegovina

$999 / 1 class + gov fee

Brunei

$1299 / 1 class + gov fee

Burkina Faso

$799 / 1 class + gov fee

Burundi

$1199 / 1 class + gov fee

Cabo Verde

$899 / 1 class + gov fee

Cameroon

$799 / 1 class + gov fee

Central African Republic (CAR)

$799 / 1 class + gov fee

Chad

$799 / 1 class + gov fee

Comoros

$799 / 1 class + gov fee

Cote d'Ivoire

$799 / 1 class + gov fee

Czechia

$999 / 1 class + gov fee

Djibouti

$1199 / 1 class + gov fee

Dominica

$1299 / 1 class + gov fee

Equatorial Guinea

$799 / 1 class + gov fee

Eritrea

$999 / 1 class + gov fee

Estonia

$1299 / 1 class + gov fee

Eswatini

$1299 / 1 class + gov fee

Fiji

$899 / 1 class + gov fee

Finland

$699 / 1 class + gov fee

Gabon

$799 / 1 class + gov fee

Gambia

$899 / 1 class + gov fee

Georgia

$799 / 1 class + gov fee

Ghana

$999 / 1 class + gov fee

Grenada

$1299 / 1 class + gov fee

Guinea

$799 / 1 class + gov fee

Guinea-Bissau

$799 / 1 class + gov fee

Guyana

$1299 / 1 class + gov fee

Iceland

$1299 / 1 class + gov fee

Ireland

$899 / 1 class + gov fee

Jamaica

$1199 / 1 class + gov fee

Kiribati

$999 / 1 class + gov fee

Kosovo

$899 / 1 class + gov fee

Kyrgyzstan

$899 / 1 class + gov fee

Latvia

$699 / 1 class + gov fee

Liberia

$999 / 1 class + gov fee

Liechtenstein

$999 / 1 class + gov fee

Lithuania

$699 / 1 class + gov fee

Luxembourg

$999 / 1 class + gov fee

Madagascar

$999 / 1 class + gov fee

Mali

$799 / 1 class + gov fee

Malta

$599 / 1 class + gov fee

Marshall Islands

$999 / 1 class + gov fee

Mauritania

$799 / 1 class + gov fee

Mauritius

$899 / 1 class + gov fee

Micronesia

$999 / 1 class + gov fee

Moldova

$999 / 1 class + gov fee

Monaco

$1399 / 1 class + gov fee

Mongolia

$599 / 1 class + gov fee

Montenegro

$899 / 1 class + gov fee

Nauru

$999 / 1 class + gov fee

Netherlands

$999 / 1 class + gov fee

Niger

$799 / 1 class + gov fee

Nigeria

$399 / 1 class + gov fee

North Macedonia

$899 / 1 class + gov fee

Palau

$999 / 1 class + gov fee

Palestine

$999 / 1 class + gov fee

Papua New Guinea

$799 / 1 class + gov fee

Rwanda

$999 / 1 class + gov fee

Saint Kitts and Nevis

$1299 / 1 class + gov fee

Saint Lucia

$1299 / 1 class + gov fee

Saint Vincent and the Grenadines

$1299 / 1 class + gov fee

Samoa

$1199 / 1 class + gov fee

San Marino

$999 / 1 class + gov fee

Sao Tome and Principe

$999 / 1 class + gov fee

Senegal

$799 / 1 class + gov fee

Seychelles

$999 / 1 class + gov fee

Sierra Leone

$999 / 1 class + gov fee

Slovenia

$899 / 1 class + gov fee

Solomon Islands

$999 / 1 class + gov fee

Somalia

$999 / 1 class + gov fee

South Sudan

$999 / 1 class + gov fee

Suriname

$1599 / 1 class + gov fee

Tajikistan

$799 / 1 class + gov fee

Tanzania

$699 / 1 class + gov fee

Timor-Leste

$999 / 1 class + gov fee

Togo

$799 / 1 class + gov fee

Tonga

$1299 / 1 class + gov fee

Trinidad and Tobago

$1399 / 1 class + gov fee

Turkmenistan

$799 / 1 class + gov fee

Tuvalu

$999 / 1 class + gov fee

Uzbekistan

$699 / 1 class + gov fee

Vanuatu

$1199 / 1 class + gov fee

Zambia

$899 / 1 class + gov fee

Zimbabwe

$899 / 1 class + gov fee

OAPI

$899 / 1 class + gov fee

ARIPO

$999 / 1 class + gov fee

Page 1 of 3